Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C2CD5 antisense RNA 1 (C2CD5-AS1)
- Target
- C2CD5-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
C2CD5 antisense RNA 1 (C2CD5-AS1) is a long non-coding RNA gene transcribed antisense to the protein-coding gene C2 calcium dependent domain containing 5 (C2CD5). Like other lncRNA antisense transcripts, its exact function remains uncharacterized, and there is no current evidence supporting a role as a therapeutic target, disease biomarker, or involvement in drug response.
02
Mechanism of action
None known
03
Biological functions
Unknown
04
Disease associations
Unknown
Beyond the preview
Go deeper on C2CD5 antisense RNA 1 (C2CD5-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C2CD5 antisense RNA 1 (C2CD5-AS1).